65 related articles for article (PubMed ID: 26410993)
1. ABDOMINAL LYMPHOMA: IMAGING WORK UP CHALLENGES AND RECOMMENDATIONS IN RESOURCE LIMITED SETUP.
Kebede AA; Bekele F; Assefa G
Ethiop Med J; 2014 Oct; 52(4):197-206. PubMed ID: 26410993
[TBL] [Abstract][Full Text] [Related]
2. PATTERNS OF ULTRASOUND FINDINGS IN ABDOMINAL LYMPHOMA PATIENTS AT TIKUR ANBESSA SPECIALIZED HOSPITAL, ADDIS ABABA, ETHIOPIA.
Kebede AA; Getaneh FB
Ethiop Med J; 2015 Oct; 53(4):199-207. PubMed ID: 27182586
[TBL] [Abstract][Full Text] [Related]
3. Imaging of pediatric lymphomas.
Abramson SJ; Price AP
Radiol Clin North Am; 2008 Mar; 46(2):313-38, ix. PubMed ID: 18619383
[TBL] [Abstract][Full Text] [Related]
4. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Punwani S; Taylor SA; Bainbridge A; Prakash V; Bandula S; De Vita E; Olsen OE; Hain SF; Stevens N; Daw S; Shankar A; Bomanji JB; Humphries PD
Radiology; 2010 Apr; 255(1):182-90. PubMed ID: 20308456
[TBL] [Abstract][Full Text] [Related]
5. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings.
Lee WK; Lau EW; Duddalwar VA; Stanley AJ; Ho YY
AJR Am J Roentgenol; 2008 Jul; 191(1):198-206. PubMed ID: 18562746
[TBL] [Abstract][Full Text] [Related]
6. Anatomic and functional imaging in the management of lymphoma.
Al-Nahhas A; Win Z; Al-Sayed Y; Khan S; Singh A; Rubello D; Gishen P
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):251-9. PubMed ID: 17538524
[TBL] [Abstract][Full Text] [Related]
7. FDG PET-CT in the management of primary breast lymphoma.
Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A
Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG-PET/CT in the management of lymphoma.
Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
[TBL] [Abstract][Full Text] [Related]
9. Role of limited whole-body PET/CT in pediatric lymphoma.
Sammer MB; Shulkin BL; Alessio A; Parisi MT
AJR Am J Roentgenol; 2011 May; 196(5):1047-55. PubMed ID: 21512070
[TBL] [Abstract][Full Text] [Related]
10. Imaging of abdominal lymphoma.
Anis M; Irshad A
Radiol Clin North Am; 2008 Mar; 46(2):265-85, viii-ix. PubMed ID: 18619381
[TBL] [Abstract][Full Text] [Related]
11. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon YL; Jones RJ; Wahl RL
J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
[TBL] [Abstract][Full Text] [Related]
12. [The acute (surgical) abdomen - epidemiology, diagnosis and general principles of management].
Grundmann RT; Petersen M; Lippert H; Meyer F
Z Gastroenterol; 2010 Jun; 48(6):696-706. PubMed ID: 20517808
[TBL] [Abstract][Full Text] [Related]
13. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
15. [Imaging examinations in lymphoma].
Terauchi T
Nihon Rinsho; 2014 Mar; 72(3):430-5. PubMed ID: 24724398
[TBL] [Abstract][Full Text] [Related]
16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
17. [Modern imaging techniques in patients with multiple myeloma].
Bannas P; Kröger N; Adam G; Derlin T
Rofo; 2013 Jan; 185(1):26-33. PubMed ID: 23196838
[TBL] [Abstract][Full Text] [Related]
18. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
19. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET in the clinical management of Hodgkin lymphoma.
Hutchings M; Eigtved AI; Specht L
Crit Rev Oncol Hematol; 2004 Oct; 52(1):19-32. PubMed ID: 15363464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
